Peelaerts, W. (2020) “Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits”, Free Neuropathology, 1, p. 33. doi: 10.17879/freeneuropathology-2020-3049.